Table 5.
Determination of BLF in pharmaceutical tablet and human blood serum using the proposed method at Bi2O3/ZnO/GCE.
Sample | Standard added (nM) | Standard foundb (nM) | Recovery (%)a | RSD (%) |
---|---|---|---|---|
B-Cin tablet (50 mg) | 100 | 98.73 ± 0.47 | 98.73 | 0.81 |
300 | 298.8 ± 0.77 | 99.6 | 0.39 | |
500 | 494.8 ± 0.63 | 98.96 | 0.59 | |
Blood serum | 100 | 99.12 ± 1.23 | 99.12 | 0.91 |
300 | 296.7 ± 0.66 | 98.9 | 0.32 | |
500 | 501.9 ± 1.02 | 100.4 | 0.75 |
[standard found/standard added] × 100.
Amount found represents the average of six observations (n = 6).